Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0025 USD | +14.42% | -7.41% | -71.26% |
2023 | Endonovo Therapeutics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 | CI |
2023 | Endonovo Therapeutics, Inc 's Sofpulse® Secures Taiwan FDA Approval | CI |
Chart: Technical Analysis
- Stock Market
- Equities
- ENDV Stock
- Charts Endonovo Therapeutics, Inc.